Furthermore, statin suppressed the function of NF-κB in colorectal cancer cells [40] and enhanced the therapeutic effect of tyrosine kinase inhibitors in patients with non-small cell lung cancer [41]. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.